18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia

Clinical trial NCT03116542 · UNKNOWN

Trial details

NCT number: NCT03116542
Sponsor: Hamad Medical Corporation
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Essential Thrombocythemia Primary Myelofibrosis, Fibrotic Stage Primary Myelofibrosis, Prefibrotic Stage

Start date: 2017-05-07
Primary completion: 2021-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.